Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Determining Aspirin’s Benefit for Cardiovascular Disease Prevention
Clinical Breakthroughs

Determining Aspirin’s Benefit for Cardiovascular Disease Prevention

By Melissa RohmanMay 15, 2020
Share
Facebook Twitter Email
Philip Greenland, MD, the Harry W. Dingman Professor of Cardiology and professor of Preventive Medicine in the Division of Epidemiology, was a co-author of the study published in Circulation.

Coronary artery calcium levels may help clinicians better identify patients with a higher risk of atherosclerotic cardiovascular disease who would benefit from taking aspirin to prevent heart attack, according to recent findings published in the journal Circulation.

Aspirin is commonly prescribed to reduce the risk of cardiovascular disease because it inhibits blood clotting, one of the primary causes of heart attacks. Unfortunately, aspirin also introduces the added risk of increased bleeding, which can cause further complications.

Previous studies have shown that in patients who have already experienced a heart attack, the overall benefit of taking aspirin for heart-related preventive purposes is greater than the risk of bleeding, so aspirin is typically recommended.

The problem, however, is understanding whether the use of aspirin as a preventative measure is justified for individuals who have never had a heart attack but may be at high risk, according to Philip Greenland, MD, the Harry W. Dingman Professor of Cardiology in the Department of Medicine and a co-author of the study.

“Even if we’re treating people optimally right now with the usual preventive therapies, which usually means treating their blood pressure and giving them cholesterol lowering medication if they need it, there are still people who are on all of those appropriate treatments and get a heart attack, so there’s an interest in trying to find additional ways to help people prevent heart attacks and seeing if aspirin is one of the ways that we could do that,” said Greenland, who is also a professor of Preventive Medicine in the Division of Epidemiology and a member of the Robert H. Lurie Comprehensive Cancer Center.

The current protocol for evaluating an individual’s risk of having a heart attack is based on a set of standard factors, including cholesterol level, blood pressure, age, patient history and family history. But it’s not always completely accurate, according to Greenland.

For the current study, Greenland and colleagues analyzed cardiac CT scans of participants involved in the Multi-Ethnic Study of Atherosclerosis (MESA), a 20 year-long study that has continued to examine early atherosclerosis — the buildup of calcium in the arteries — in more than 6,000 men and women across the United States.

Specifically, the investigators analyzed coronary artery calcium levels in the cardiac CT scans of 3,540 participants from MESA, all of whom had never taken aspirin, were younger than 70 years old and did not present with a high bleeding risk.

From the data, the team determined that participants with higher coronary artery calcium levels, or arterial blockage, had a higher risk of a heart attack. The team then combined this information with the standardized risk factors for having a heart attack to identify a new threshold to determine whether or not a patient who has never had a heart attack should take aspirin for preventative measures.

“This study demonstrates very nicely why long-term research studies are so important because there’s no way you can get this information just from examining medical records,” Greenland said.

Greenland noted that in situations where a patient is at the borderline for risk factors, the final decision may come down to the patient accepting the idea of taking a medication daily to try to prevent a heart attack that may or may not happen.

Currently, Greenland is using data from the same group of MESA participants in an additional study that aims to better understand the cause of atrial fibrillation and the relationship between atrial fibrillation and stroke.

Greenland is a member of, and the founding director of the Northwestern University Clinical and Translational Sciences (NUCATS) Institute. This study was supported by contracts HHSN268201500003I, N01-HC-95159 through N01- HC-95169 from the National Heart, Lung, and Blood Institute, and the grants UL1-TR-000040, UL1-TR-001079, UL1-TR-001420 and UL1-TR-001881 from the National Center for Advancing Translational Sciences.

Cardiology Research
Share. Facebook Twitter Email

Related Posts

Epigenetic Biomarkers Predict CVD Risk

Jun 28, 2022

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Comments are closed.

Latest News

Epigenetic Biomarkers Predict CVD Risk

Jun 28, 2022

Student Spearheads Ukraine Aid Efforts

Jun 27, 2022

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Combination Treatment May Improve Quality of Life in Kidney Cancer

Jun 23, 2022
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20220617_NM_0434
20220617_NM_0858
20220617_NM_0643
20220617_NM_0835
20220617_NM_0544
20220617_NM_0450
20220617_NM_0790
20220617_NM_0811
20220617_NM_0851
20220617_NM_0696
20220617_NM_0779
20220617_NM_0838

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2022 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.